| Product Code: ETC4720315 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Burkina Faso`s human insulin import market in 2024 continued to be dominated by imports from Denmark, France, India, Germany, and Belgium, reflecting a high concentration with a high Herfindahl-Hirschman Index (HHI). Despite a notable Compound Annual Growth Rate (CAGR) of 6.42% from 2020 to 2024, the growth rate experienced a significant decline of -40.89% from 2023 to 2024. This dynamic market trend suggests a fluctuating landscape in the human insulin import sector in Burkina Faso, potentially influenced by various factors impacting trade relationships and market demands.

Burkina Fasos human insulin market is crucial for managing the countrys growing diabetes burden. The market is driven by increasing awareness, improved healthcare access, and efforts to make insulin more affordable and widely available.
The human insulin market in Burkina Faso is driven by the increasing prevalence of diabetes and the need for effective management of the condition. The growing awareness of diabetes care and advancements in insulin formulation are contributing to market growth. Efforts to improve access to diabetes treatment and management in Burkina Faso are also supporting the expansion of the human insulin market.
Challenges in the human insulin market include limited access to advanced insulin products and a reliance on imports. There is also a need for improved distribution channels and education about diabetes management.
Burkina Fasos policies in the human insulin market focus on improving access to diabetes treatment. The government may support initiatives to increase the availability of insulin and enhance healthcare infrastructure for diabetes care.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Human Insulin Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Human Insulin Market - Industry Life Cycle |
3.4 Burkina Faso Human Insulin Market - Porter's Five Forces |
3.5 Burkina Faso Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Burkina Faso Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Burkina Faso Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Burkina Faso Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Burkina Faso Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Burkina Faso Human Insulin Market Trends |
6 Burkina Faso Human Insulin Market Segmentations |
6.1 Burkina Faso Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Burkina Faso Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Burkina Faso Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Burkina Faso Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Burkina Faso Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Burkina Faso Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Burkina Faso Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Burkina Faso Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Burkina Faso Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Burkina Faso Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Burkina Faso Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Burkina Faso Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Burkina Faso Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Burkina Faso Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Burkina Faso Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Burkina Faso Human Insulin Market Import-Export Trade Statistics |
7.1 Burkina Faso Human Insulin Market Export to Major Countries |
7.2 Burkina Faso Human Insulin Market Imports from Major Countries |
8 Burkina Faso Human Insulin Market Key Performance Indicators |
9 Burkina Faso Human Insulin Market - Opportunity Assessment |
9.1 Burkina Faso Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Burkina Faso Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Burkina Faso Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Burkina Faso Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Burkina Faso Human Insulin Market - Competitive Landscape |
10.1 Burkina Faso Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |